Abstract: The inventors have proposed a novel panel of human plasma protein biomarkers for diagnosing hepatic fibrosis and cirrhosis. Presently there is no reliable non-invasive way of assessing liver fibrosis. A 2D-PAGE based proteomics study was used to identify potential fibrosis biomarkers. Plasma from patients with hepatic cirrhosis induced by infection with the hepatitis C virus (HCV) were analysed. Several proteins associated with liver scarring and potentially also related to viral infection were identified. These proteins include 14-3-3 protein zeta/delta, adiponectin, afamin, alpha- 1 -antitrypsin, alpha-2-HS-glycoprotein, apolipoprotein C-III, apolipoprotein E, C4b-binding protein beta chain, intact/cleaved complement C3dg, corticosteroid-binding globulin, fibrinogen gamma chain, beta haptoglobin at pH 5.46 - 5.49, haptoglobin-related protein, hemopexin, immunoglobulin J chain, leucine-rich alpha-2-glycoprotein, lipid transfer inhibitor protein, retinol-binding protein 4, serum paraoxonase/arylesterase 1, sex hormone-binding globulin and zinc-alpha-2- glycoprotein. These biomarkers can be used in conjunction with polypeptides in WO/2008/031051. The concentrations of these novel biomarkers can be determined using an immunoassay where the concentrations would reflect the extent of fibrosis. A fibrosis scoring scale for each of the novel biomarkers is proposed. The additive result from the scores of all the novel biomarkers would give a more reliable indication of the degree of fibrosis rather than examining individual biomarkers.
PLEASE SEE THE SPECIFICATION ATTACHED.
| # | Name | Date |
|---|---|---|
| 1 | 8623-CHENP-2011-AbandonedLetter.pdf | 2018-04-23 |
| 1 | Form5_As Filed_23-11-2011.pdf | 2011-11-23 |
| 2 | 8623-CHENP-2011-FER.pdf | 2017-10-04 |
| 2 | Form3_As Filed_23-11-2011.pdf | 2011-11-23 |
| 3 | Form2 Title Page_Complete_23-11-2011.pdf | 2011-11-23 |
| 3 | Correspondence by Agent_Form3_17-03-2015.pdf | 2015-03-17 |
| 4 | Form3_After Filing_17-03-2015.pdf | 2015-03-17 |
| 4 | Drawing_As Filed_23-11-2011.pdf | 2011-11-23 |
| 5 | Correspondence by Agent_Notarized Assignment_25-11-2011.pdf | 2011-11-25 |
| 5 | Correspondence by Agent_Form18_17-04-2013.pdf | 2013-04-17 |
| 6 | Correspondence by Agent_Form3_17-04-2013.pdf | 2013-04-17 |
| 6 | Assignment_After Filing_25-11-2011.pdf | 2011-11-25 |
| 7 | Form3_After Filing_17-04-2013.pdf | 2013-04-17 |
| 7 | Form26_Power of Attorney_25-01-2012.pdf | 2012-01-25 |
| 8 | Correspondence by Agent_PA_25-01-2012.pdf | 2012-01-25 |
| 8 | Correspondence by Agent_Form3_29-03-2012.pdf | 2012-03-29 |
| 9 | Form2 Title Page_Complete_01-02-2012.pdf | 2012-02-01 |
| 9 | Form3_After Filing_29-03-2012.pdf | 2012-03-29 |
| 10 | Correspondence by Agent_Form13_01-02-2012.pdf | 2012-02-01 |
| 10 | Form1_After Filing_01-02-2012.pdf | 2012-02-01 |
| 11 | Form13_Address of service Change_01-02-2012.pdf | 2012-02-01 |
| 12 | Correspondence by Agent_Form13_01-02-2012.pdf | 2012-02-01 |
| 12 | Form1_After Filing_01-02-2012.pdf | 2012-02-01 |
| 13 | Form2 Title Page_Complete_01-02-2012.pdf | 2012-02-01 |
| 13 | Form3_After Filing_29-03-2012.pdf | 2012-03-29 |
| 14 | Correspondence by Agent_Form3_29-03-2012.pdf | 2012-03-29 |
| 14 | Correspondence by Agent_PA_25-01-2012.pdf | 2012-01-25 |
| 15 | Form26_Power of Attorney_25-01-2012.pdf | 2012-01-25 |
| 15 | Form3_After Filing_17-04-2013.pdf | 2013-04-17 |
| 16 | Assignment_After Filing_25-11-2011.pdf | 2011-11-25 |
| 16 | Correspondence by Agent_Form3_17-04-2013.pdf | 2013-04-17 |
| 17 | Correspondence by Agent_Form18_17-04-2013.pdf | 2013-04-17 |
| 17 | Correspondence by Agent_Notarized Assignment_25-11-2011.pdf | 2011-11-25 |
| 18 | Drawing_As Filed_23-11-2011.pdf | 2011-11-23 |
| 18 | Form3_After Filing_17-03-2015.pdf | 2015-03-17 |
| 19 | Form2 Title Page_Complete_23-11-2011.pdf | 2011-11-23 |
| 19 | Correspondence by Agent_Form3_17-03-2015.pdf | 2015-03-17 |
| 20 | Form3_As Filed_23-11-2011.pdf | 2011-11-23 |
| 20 | 8623-CHENP-2011-FER.pdf | 2017-10-04 |
| 21 | Form5_As Filed_23-11-2011.pdf | 2011-11-23 |
| 21 | 8623-CHENP-2011-AbandonedLetter.pdf | 2018-04-23 |
| 1 | 8623-CHENP-2011(1)_04-10-2017.pdf |